A longitudinal study of UK military personnel offered anthrax vaccination: Informed choice, symptom reporting, uptake and pre-vaccination health

Murphy, Dominic; Marteau, Theresa M.; Wessely, Simon

doi:10.1016/j.vaccine.2011.12.030

Cited by 7 publications

(6 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Such misinformation may in itself heighten awareness of subjective symptoms, leading to increased reporting of side effects. There is evidence from military studies of vaccine administration that military personnel who perceived that they might experience side effects were more likely to do so 20. We suggest that while more research is warranted, sensible and evidence-based reporting of the risks of mefloquine and risks of malaria should be readily available to ensure that troops who are prescribed the medication are not unduly worried, while the medical staff who prescribe it remain alert to its potential to cause side effects.…”

Section: Directions For Future Researchmentioning

confidence: 98%

Mefloquine for malaria prophylaxis in military personnel

Williamson

Blamey

Sharpley³

et al. 2020

BMJ Mil Health

View full text Add to dashboard Cite

Section: Directions For Future Researchmentioning

confidence: 98%

Mefloquine for malaria prophylaxis in military personnel

Williamson

Blamey

Sharpley³

et al. 2020

BMJ Mil Health

View full text Add to dashboard Cite

“…120 The anthrax vaccine in military populations has caused considerable scepticism regarding the need for, safety, and efficacy of the vaccine. [121][122][123] Clinicians and public health personnel should have access to up-to-date information, and the general public should be provided with nontechnical information and simple instructions on how to act during an emergency. Sandman 120 has proposed that "one should not over-reassure, ack nowledge uncertainty, and share dilemmas".…”

Section: Risk Communicationmentioning

confidence: 99%

Confronting the threat of bioterrorism: realities, challenges, and defensive strategies

Green

LeDuc

Cohen

et al. 2019

The Lancet Infectious Diseases

View full text Add to dashboard Cite

Global terrorism is a rapidly growing threat to world security, and increases the risk of bioterrorism. In this Review, we discuss the potential threat of bioterrorism, agents that could be exploited, and recent developments in technologies and policy for detecting and controlling epidemics that have been initiated intentionally. The local and international response to infectious disease epidemics, such as the severe acute respiratory syndrome and west African Ebola virus epidemic, revealed serious shortcomings which bioterrorists might exploit when intentionally initiating an epidemic. Development of new vaccines and antimicrobial therapies remains a priority, including the need to expedite clinical trials using new methodologies. Better means to protect health-care workers operating in dangerous environments are also needed, particularly in areas with poor infrastructure. New and improved approaches should be developed for surveillance, early detection, response, effective isolation of patients, control of the movement of potentially infected people, and risk communication. Access to dangerous pathogens should be appropriately regulated, without reducing progress in the development of countermeasures. We conclude that preparedness for intentional outbreaks has the important added value of strengthening preparedness for natural epidemics, and vice versa. This is the second in a Series of three papers about terrorism and health in collaboration with The Lancet Psychiatry

show abstract

“…Data from the UK and US suggest that anthrax vaccination prevents disease . Anthrax vaccination is considered safe . Injection site reactions occur in 47% of AVP recipients .…”

Section: Anthraxmentioning

confidence: 99%

“…Injection site reactions occur in 47% of AVP recipients . Follow‐up data ranging from 3 to 6 years show no overall adverse health effects following receipt of AVP .…”

Section: Anthraxmentioning

confidence: 99%